Related Articles
The AP-1/NF-κB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia
Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia
Protein turnover in skeletal muscle of the diabetic rat: activation of ubiquitin-dependent proteolysis.
Formoterol treatment down-regulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats
Cancer cachexia results in an increase in TNF-α receptor gene expression in both skeletal muscle and adipose tissue